AAAAAA
Results: 1-25/31
Authors:
Kucuk, O
Sarkar, FH
Sakr, W
Djuric, Z
Pollak, MN
Khachik, F
Li, YW
Banerjee, M
Grignon, D
Bertram, JS
Crissman, JD
Pontes, EJ
Wood, DP
Citation: O. Kucuk et al., Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy, CANC EPID B, 10(8), 2001, pp. 861-868
Authors:
Curran, WJ
Ajani, J
Ang, K
Bonanni, R
Bruner, D
Byhardt, R
Eisenberg, B
Gillin, MT
Ginsberg, RJ
Greven, K
Grignon, D
Hammond, E
Layne, E
McCormick, B
Mehta, M
Michalski, J
Okunieff, P
Sandler, H
Scarantino, CW
Willett, C
Citation: Wj. Curran et al., Radiation Therapy Oncology Group, research plan 2002-2006, INT J RAD O, 51(3), 2001, pp. V
Authors:
Pilepich, MV
Winter, K
John, MJ
Mesic, JB
Sause, W
Rubin, P
Lawton, C
Machtay, M
Grignon, D
Citation: Mv. Pilepich et al., Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate, INT J RAD O, 50(5), 2001, pp. 1243-1252
Authors:
Narain, V
Tiguert, R
Banerjee, M
Grignon, D
Wood, DP
Powell, IJ
Citation: V. Narain et al., Biochemical recurrence after radical prostatectomy in black and white American men with a positive or negative family history of prostate cancer, J UROL, 165(2), 2001, pp. 474-477
Authors:
Garnick, MB
Fair, WR
Bostwick, D
Debruyne, F
Fourcroy, J
Grignon, D
Porterfield, H
Sufrin, G
Thrasher, B
Hart, C
Citation: Mb. Garnick et al., Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer - Overview consensus statement, MOL UROL, 4(3), 2000, pp. 89-92
Authors:
Fair, W
Bostwick, D
Civantos, F
Klotz, L
Cookson, M
Sakr, W
Garnick, M
Stone, N
Grignon, D
Citation: W. Fair et al., Epidemiology and molecular biology of early prostatic neoplasia - Open discussion following Dr. Sakr's presentation, MOL UROL, 4(3), 2000, pp. 115-115
Authors:
Stone, N
Civantos, F
Grignon, D
Citation: N. Stone et al., Difficulties in interpreting specimens after neoadjuvant hormonal therapy and radiation with illustration of neuroendocrine differentiation - Open discussion following Dr. Civantos' presentation, MOL UROL, 4(3), 2000, pp. 123-123
Authors:
Grignon, D
D'Amico, AV
Zietman, A
Moul, J
Bostwick, D
Citation: D. Grignon et al., Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer - Open discussionfollowing Dr. D'Amico's presentation, MOL UROL, 4(3), 2000, pp. 177-177
Authors:
D'Amico, A
Garzotto, M
Bruchovsky, N
Sufrin, G
Zietman, AL
Stone, N
Grignon, D
Civantos, F
Bostwick, D
Klotz, L
Citation: A. D'Amico et al., Combined androgen deprivation with radiotherapy for prostate cancer: Does it make sense? Open discussion following Dr. Zietman's and Dr. Garzotto's presentations, MOL UROL, 4(3), 2000, pp. 215-215
Authors:
Stone, N
Fair, WR
Grignon, D
Bruchovsky, N
Cookson, M
Garnick, M
Sylvester, J
Klotz, L
Zietman, A
Citation: N. Stone et al., Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer - Open discussion following Dr. Fair's presentation, MOL UROL, 4(3), 2000, pp. 249-250
Authors:
Thrasher, B
Moul, JW
Debruyne, F
Sylvester, J
Fair, W
Grignon, D
Citation: B. Thrasher et al., Hormonal therapy options for biochemical recurrence of prostate cancer after local therapy - Open discussion following Dr. Moul's presentation, MOL UROL, 4(3), 2000, pp. 273-273
Authors:
Valicenti, R
Lu, JD
Pilepich, M
Asbell, S
Grignon, D
Citation: R. Valicenti et al., Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the radiation therapy oncology group trials, J CL ONCOL, 18(14), 2000, pp. 2740-2746
Authors:
Roach, M
Lu, JD
Pilepich, MV
Asbell, SO
Mohuidden, M
Terry, R
Grignon, D
Citation: M. Roach et al., Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on radiation therapy oncology group clinical trials, INT J RAD O, 47(3), 2000, pp. 609-615
Authors:
Roach, M
Lu, JD
Pilepich, MV
Asbell, SO
Mohuidden, M
Terry, R
Grignon, D
Lawton, C
Shipley, W
Cox, J
Citation: M. Roach et al., Predicting long-term survival, and the need for hormonal therapy: A meta-analysis of RTOG prostate cancer trials, INT J RAD O, 47(3), 2000, pp. 617-627
Authors:
Powell, IJ
Banerjee, M
Novallo, M
Sakr, W
Grignon, D
Wood, DP
Pontes, JE
Citation: Ij. Powell et al., Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease, UROLOGY, 55(2), 2000, pp. 246-251
Authors:
Powell, IJ
Banerjee, M
Novallo, M
Sakr, W
Grignon, D
Wood, DP
Pontes, JE
Citation: Ij. Powell et al., Should the age specific prostate specific antigen cutoff for prostate biopsy be higher for black than for white men older than 50 years?, J UROL, 163(1), 2000, pp. 146-148
Authors:
Timar, J
Raso, E
Dome, B
Li, L
Grignon, D
Nie, D
Honn, KV
Hagmann, W
Citation: J. Timar et al., Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential, INT J CANC, 87(1), 2000, pp. 37-43
Authors:
Garnick, MB
Fair, WR
Goldenberg, SL
Gleave, M
Grignon, D
Fourcroy, J
Sufrin, G
Porterfield, H
Hart, C
Citation: Mb. Garnick et al., Fourth International Conference on Neoadjuvant Hormonal Therapy of Prostate Cancer - March 12-13, 1999 - Boston, Massachusetts - Overview consensus statement, MOL UROL, 3(3), 1999, pp. 171-174
Authors:
Howell, S",Civantos,"Gleave, M
Labrie, F
Fair, W
Albersten, P
D'Amico, A
Stone, N
Grignon, D
Citation: M. Howell, S",civantos,"gleave et al., Open discussion following Dr. Civantos' presentation, MOL UROL, 3(3), 1999, pp. 205-206
Authors:
Garnick, M",D'Amico,"Stone, N
Sylvester, J
Grignon, D
Albertsen, P
Trachtenberg, J
Goldenberg, L
Fair, W
Citation: N. Garnick, M",d'Amico,"stone et al., Open discussion following Dr. D'Amico's presentation, MOL UROL, 3(3), 1999, pp. 213-215
Authors:
Lawton, CA
Grignon, D
Newhouse, JH
Schellhammer, PF
Kuban, DA
Citation: Ca. Lawton et al., Prostatic carcinoma, RADIOGRAPHI, 19(1), 1999, pp. 185-203
Authors:
Tefilli, MV
Gheiler, EL
Tiguert, R
Banerjee, M
Sakr, W
Grignon, D
Wood, DP
Pontes, JE
Citation: Mv. Tefilli et al., Role of radical prostatectomy in patients with prostate cancer of high Gleason score, PROSTATE, 39(1), 1999, pp. 60-66
Authors:
Shekarriz, B
Upadhyay, J
Wood, DP
Hinman, J
Raasch, J
Cummings, GD
Grignon, D
Littrup, PJ
Citation: B. Shekarriz et al., Vesicourethral anastomosis biopsy after radical prostatectomy: Predictive value of prostate-specific antigen and pathologic stage, UROLOGY, 54(6), 1999, pp. 1044-1048
Authors:
Barroso, U
Oskanian, P
Tefilli, MV
Banerjee, M
Grignon, D
Sakr, W
Pontes, JE
Powell, IJ
Citation: U. Barroso et al., Population-based study of pelvic lymph node positivity in clinically localized prostate cancer: A study comparing African Americans and whites, UROLOGY, 53(1), 1999, pp. 187-191
Long-term survival after radiotherapy alone: Radiation therapy oncology group prostate cancer trials
Authors:
Roach, M
Lu, JD
Pilepich, MV
Asbell, SO
Mohiuddin, M
Terry, R
Grignon, D
Citation: M. Roach et al., Long-term survival after radiotherapy alone: Radiation therapy oncology group prostate cancer trials, J UROL, 161(3), 1999, pp. 864-868